Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potential value and limitation of dual inhibitors of PI3K and mTOR in the treatment of cancer.

× No keyword cloud information.

6 in total

1. PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer.

Authors: Huanan Wang; Lingling Zhang; Xu Yang; Yipeng Jin; Shimin Pei; Di Zhang; Hong Zhang; Bin Zhou; Yingjie Zhang; Degui Lin
Journal: Oncotarget Date: 2015-06-10

2. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.

Authors: L Chang; P H Graham; J Hao; J Ni; J Bucci; P J Cozzi; J H Kearsley; Y Li
Journal: Cell Death Dis Date: 2013-10-24 Impact factor: 8.469

Review 3. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.

Authors: Valdenizia R Silva; Luciano de S Santos; Rosane B Dias; Claudio A Quadros; Daniel P Bezerra
Journal: Cancer Commun (Lond) Date: 2021-11-17

4. Effective inhibition of colon cancer cell growth with MgAl-layered double hydroxide (LDH) loaded 5-FU and PI3K/mTOR dual inhibitor BEZ-235 through apoptotic pathways.

Authors: Jiezhong Chen; Renfu Shao; Li Li; Zhi Ping Xu; Wenyi Gu
Journal: Int J Nanomedicine Date: 2014-07-16

5. Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis.

Authors: Hong Zou; Li Li; Ines Garcia Carcedo; Zhi Ping Xu; Michael Monteiro; Wenyi Gu
Journal: Int J Nanomedicine Date: 2016-05-05

6. Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer.

Authors: Fei Yang; Jun-Yi Gao; Hua Chen; Zhen-Hua Du; Xue-Qun Zhang; Wei Gao
Journal: Onco Targets Ther Date: 2017-09-11 Impact factor: 4.147

6 in total